Cytarabine and Cholecystitis infective - a phase IV clinical study of FDA data

Summary:

Cholecystitis infective is reported as a side effect among people who take Cytarabine (cytarabine), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Methotrexate, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Cholecystitis infective when taking Cytarabine. It is created by eHealthMe based on reports of 65,319 people who have side effects when taking Cytarabine from the FDA, and is updated regularly.

What is Cytarabine?

Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 65,358 Cytarabine users. Check the latest studies of Cytarabine.

What is Cholecystitis infective?

Cholecystitis infective (infection of gallbladder capable to infect other organs) is found to be associated with 392 drugs and 405 conditions by eHealthMe. Check the latest studies of Cholecystitis infective.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

65,319 people reported to have side effects when taking Cytarabine.
Among them, 16 people (0.02%) have Cholecystitis infective.

Could Cytarabine cause Cholecystitis infective?

Among these 16 people:

How long have people been on Cytarabine when they have Cholecystitis infective? *

What is the gender of people who have Cholecystitis infective when taking Cytarabine? *

female: 21.43 %
male: 78.57 %

What is the age of people who have Cholecystitis infective when taking Cytarabine? *

What are other drugs people take besides Cytarabine? *

What are other side effects people have besides Cholecystitis infective? *

Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 7 people, 43.75%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 7 people, 43.75%
Pneumonia Respiratory Syncytial Viral (respiratory syncytial virus (rsv) is a very common virus that leads to mild, cold-like symptoms in adults and older healthy children): 5 people, 31.25%
Necrosis (the death of body tissue): 4 people, 25.00%
Septic Shock (shock due to blood infection): 3 people, 18.75%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 18.75%
Infective Aneurysm (infective bulge or ""ballooning"" in the wall of an artery): 2 people, 12.50%
Cholecystitis Acute (rapid infection of gallbladder): 2 people, 12.50%
Dyspnea (difficult or laboured breathing): 2 people, 12.50%
Endophthalmitis (inflammation of the internal coats of the eye): 2 people, 12.50%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 37.50%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 18.75%
Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 18.75%
Neutropenic Colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition): 1 person, 6.25%
Lymphoma (cancer that begins in immune system cells): 1 person, 6.25%
Fusarium Infection (fungal infection): 1 person, 6.25%
Endophthalmitis (inflammation of the internal coats of the eye): 1 person, 6.25%
Central Nervous System Stimulation: 1 person, 6.25%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Cytarabine and have Cholecystitis infective?

- Check whether Cholecystitis infective is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cytarabine:

Cytarabine (65,358 reports)

Browse all side effects of Cytarabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cholecystitis infective:

Cholecystitis infective (392 drugs)

Browse all the conditions that are associated with Cholecystitis infective:

Cholecystitis infective (405 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cytarabine (the active ingredients of Cytarabine) and Cytarabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.